Novo Nordisk CEO says experimental weight loss pill could become a best in class drug
March 08, 2024 at 12:37 PM EST
Lars Fruergaard Jørgensen's remarks came one day after Novo Nordisk impressed investors with early-stage trial data on amycretin.
